Scarica l'app Stockscreener
5.84
11.88%
0.62
Dopo l'orario di chiusura:
5.73
-0.11
-1.88%
Precedente Chiudi:
$5.22
Aprire:
$5.31
Volume 24 ore:
347.93K
Relative Volume:
3.07
Capitalizzazione di mercato:
$497.94M
Reddito:
-
Utile/perdita netta:
$-29.64M
Rapporto P/E:
-13.58
EPS:
-0.43
Flusso di cassa netto:
$-39.43M
1 W Prestazione:
+16.10%
1M Prestazione:
+50.13%
6M Prestazione:
+84.23%
1 anno Prestazione:
+84.23%
Intervallo 1D:
$5.20
$5.87
Intervallo di 1 settimana:
$4.75
$5.87
Portata 52W:
$2.30
$5.87
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Nome
Alpha Tau Medical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRTS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
5.84 | 445.08M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-15 | Iniziato | Citigroup | Buy |
| 2023-04-24 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Iniziato | Piper Sandler | Overweight |
| 2022-04-04 | Iniziato | Citigroup | Buy |
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks
Alpha Tau reports new positive results in two upcoming presentations - marketscreener.com
Alpha Tau Reports New Positive Results in Two Upcoming - GlobeNewswire
Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical - TipRanks
Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation - The Globe and Mail
Bond Watch: Is Alpha Tau Medical Ltd stock a buy before product launchesJuly 2025 Gainers & Long-Term Capital Growth Strategies - moha.gov.vn
Alpha Tau submits first pre-market approval module to the FDA - marketscreener.com
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy - TipRanks
Alpha Tau submits PMA module to FDA for Alpha DaRT - TipRanks
Alpha Tau Submits First Pre-Market Approval Module to the - GlobeNewswire
What drives Alpha Tau Medical Ltd stock priceSwing Trading Watchlist & High Return Capital Gains - earlytimes.in
Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Graphite India Limited At Decision Level — Rebound or ResistanceSupport Zone Identification & Double Digit Profit Strategies - bollywoodhelpline.com
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 58.8% in December - MarketBeat
Pharma News: Can Alpha Tau Medical Ltd Equity Warrant stock hit record highs again2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
How supply chain issues affect Alpha Tau Medical Ltd. stock2025 Market Overview & AI Driven Price Predictions - Улправда
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - MSN
Will Alpha Tau Medical Ltd. stock attract more institutional investorsPortfolio Performance Report & Accurate Trade Setup Notifications - Улправда
Will Alpha Tau Medical Ltd. Equity Warrant stock sustain high P E ratios2025 Retail Activity & AI Based Trade Execution Alerts - Улправда
Entry Recap: How supply chain issues affect Alpha Tau Medical Ltd. stockJuly 2025 Earnings & Weekly High Potential Alerts - Улправда
Why Alpha Tau Medical Ltd. stock remains a top recommendationBuy Signal & Intraday High Probability Setup Alerts - Улправда
Will Alpha Tau Medical Ltd. stock deliver shareholder valueQuarterly Profit Review & Verified Short-Term Plans - Улправда
Earnings Miss: How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stock2025 Sector Review & Smart Swing Trading Alerts - Улправда
Market Recap: What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Drop Watch & Risk Managed Investment Signals - Улправда
Alpha Tau Medical’s innovative cancer treatment study update: A potential game-changer - MSN
Is Alpha Tau Medical Ltd. stock a buy before product launches2025 AllTime Highs & Fast Gain Swing Alerts - Bölüm Sonu Canavarı
Will Alpha Tau Medical Ltd. Equity Warrant stock outperform Nasdaq index2025 Volume Leaders & AI Powered Market Trend Analysis - Улправда
Why Alpha Tau Medical Ltd. stock is seen as undervaluedTrade Volume Report & Stock Timing and Entry Methods - Улправда
Will Alpha Tau Medical Ltd. stock benefit from infrastructure spendingQuarterly Earnings Summary & AI Optimized Trade Strategies - DonanımHaber
Will Alpha Tau Medical Ltd. stock attract ESG investorsWeekly Stock Report & Daily Volume Surge Signals - Улправда
How Alpha Tau Medical Ltd. Equity Warrant stock performs during Fed tightening cyclesWeekly Profit Recap & Long-Term Growth Portfolio Plans - DonanımHaber
Aug Levels: Will Alpha Tau Medical Ltd. stock attract more institutional investorsJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Alpha Tau Medical Ltd. stock positioned for long term growthJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings seasonJuly 2025 News Drivers & Weekly Sector Rotation Insights - Улправда
Is Alpha Tau Medical Ltd. stock positioned well for digital economyBond Market & Breakout Confirmation Alerts - Улправда
Buyout Rumor: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Technical Overview & Free Real-Time Market Sentiment Alerts - Улправда
Will Alpha Tau Medical Ltd. stock outperform tech sector in 2025Market Risk Summary & Accurate Intraday Trade Tips - Улправда
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch - TipRanks
Alpha Tau Medical to Present Corporate Update at J.P. Morgan 2026 Healthcare Conference - TipRanks
Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Alpha Tau Medical (NASDAQ: DRTS) to present at J.P. Morgan 2026 event - Stock Titan
Risk Report: Is Alpha Tau Medical Ltd. Equity Warrant stock a top pick in earnings season2025 Market Outlook & Consistent Profit Trade Alerts - Улправда
How rising interest rates impact Alpha Tau Medical Ltd. Equity Warrant stockJuly 2025 Final Week & Precise Buy Zone Identification - Улправда
What insider trading reveals about Alpha Tau Medical Ltd. stockWeekly Risk Report & Weekly Stock Breakout Alerts - Улправда
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer - TipRanks
Death Cross: Will Alpha Tau Medical Ltd Equity Warrant stock maintain growth story2025 Top Gainers & Risk Controlled Stock Alerts - moha.gov.vn
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update - TipRanks
Alpha Tau Medical Ltd Azioni (DRTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):